Jennifer Stevens has been the Chief Regulatory Officer at TriSalus since March 2022 and served as TriSalus’ Senior Vice President of Regulatory Affairs from March 2021 to March 2022.
Previously, Jennifer held several progressive leadership roles with EMD Serono Inc., a division of Merck KGaA focused on biopharmaceuticals, from January 2016 through March 2021, including as Acting Head of US Oncology Hub — Regulatory Affairs. Previously, Jennifer was Regulatory Counsel for the U.S. Food and Drug Administration from July 2008 to December 2012. Earlier in her career, Jennifer was a practicing attorney at several global law firms, achieving partnership at Kirkland & Ellis LLP.
Jennifer received her B.A. in Political Sciences from the University of Illinois and her J.D. from George Washington University.
